AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of Symptomatic COVID-19. Levin MJ, Ustianowski A, Thomas S, Templeton A, et al. Clin Infect Dis 2022 Nov 22:ciac899. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Levin MJ, Ustianowski A, Thomas S, Templeton A, et al. AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of Symptomatic COVID-19. Clin Infect Dis 2022 Nov 22:ciac899. doi: 10.1093.
PMID: 36411267